Page last updated: 2024-11-07

spironolactone and Ankylosing Spondylarthritis

spironolactone has been researched along with Ankylosing Spondylarthritis in 2 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research Excerpts

ExcerptRelevanceReference
"Chronic inflammation in ankylosing spondylitis (AS) is associated with vascular endothelial dysfunction which leads to accelerated atherosclerosis."1.39Spironolactone improves endothelial dysfunction in ankylosing spondylitis. ( Garg, N; Kaur, L; Khichi, D; Syngle, A; Verma, I; Vohra, K, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Syngle, A1
Vohra, K1
Khichi, D1
Garg, N1
Verma, I1
Kaur, L1
Suh, YS1
Kim, HO1
Cheon, YH1
Jo, W1
Hong, J1
Lee, SI1

Reviews

1 review available for spironolactone and Ankylosing Spondylarthritis

ArticleYear
Ankylosing spondylitis associated with primary aldosteronism in a middle-aged woman.
    The Korean journal of internal medicine, 2017, Volume: 32, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Biological Products; Biomarkers; Drug

2017

Other Studies

1 other study available for spironolactone and Ankylosing Spondylarthritis

ArticleYear
Spironolactone improves endothelial dysfunction in ankylosing spondylitis.
    Clinical rheumatology, 2013, Volume: 32, Issue:7

    Topics: Adolescent; Adult; Atherosclerosis; Blood Sedimentation; Brachial Artery; C-Reactive Protein; Diuret

2013